Mejía-Vilet Juan M, Márquez-Martínez Manuel A, Cordova-Sanchez Bertha M, Ibargüengoitia Mónica Chapa, Correa-Rotter Ricardo, Morales-Buenrostro Luis E
Department of Nephrology and Mineral Metabolism, National Sciences and Nutrition Institute Salvador Zubiran, México.
Department of Radiology and Image "Dr. Adan Pitol Croda", National Sciences and Nutrition Institute Salvador Zubiran, México.
Nephrology (Carlton). 2018 Jun;23(6):523-529. doi: 10.1111/nep.13055.
To derive a simple risk score to predict the individual risk of major complications for patients undergoing a percutaneous renal biopsy procedure of native kidneys.
The risk score was derived from a cohort of 1205 adult patients subjected to percutaneous renal biopsy and assigned to training and validation datasets. Factors associated with major complications were derived from univariate analysis and then modelled by stepwise multivariate logistic regression. Based on the odds ratio, independent predictors were assigned a weighted integer. The risk score is calculated from the sum of the integers.
The overall incidence of major complications was 3.2%. Independent factors associated with MC were lower pre-biopsy haemoglobin, lower platelets, higher blood urea nitrogen, documented chronic kidney disease features in pre-biopsy ultrasound (US) and the presence of haematoma in the post-biopsy US. A score for pre-biopsy evaluation included the first four predictors and stratified patients in three categories with increasing risk at higher scores (low-risk 0.1%, moderate-risk 3.0% and high-risk 26.1%). The score demonstrated good discriminative power (AUC = 0.872). The addition of post-biopsy US findings increased the discriminative power (AUC = 0.938). A higher post-biopsy risk score was also associated with a higher incidence of MC (low-risk 0.2%, moderate-risk 2.7%, high-risk 16.9%).
The risk of major complications after a percutaneous renal biopsy can be assessed by a simple risk score calculated from readily available information.
推导一个简单的风险评分,以预测接受经皮肾穿刺活检术的患者发生主要并发症的个体风险。
该风险评分来自1205例接受经皮肾穿刺活检的成年患者队列,并分为训练集和验证集。与主要并发症相关的因素通过单因素分析得出,然后通过逐步多因素逻辑回归进行建模。根据比值比,为独立预测因素分配一个加权整数。风险评分由这些整数的总和计算得出。
主要并发症的总体发生率为3.2%。与主要并发症相关的独立因素包括活检前血红蛋白水平较低、血小板计数较低、血尿素氮水平较高、活检前超声(US)记录的慢性肾脏病特征以及活检后超声检查发现血肿。活检前评估的评分包括前四个预测因素,并将患者分为三类,评分越高风险越高(低风险0.1%,中度风险3.0%,高风险26.1%)。该评分显示出良好的鉴别能力(AUC = 0.872)。活检后超声检查结果的加入提高了鉴别能力(AUC = 0.938)。活检后风险评分越高,主要并发症的发生率也越高(低风险0.2%,中度风险2.7%,高风险16.9%)。
经皮肾穿刺活检术后主要并发症的风险可以通过根据易于获得的信息计算出的简单风险评分来评估。